A systems biology approach to drug development clinical testing of biomarkers for the anti-ErbB3 antibody MM-121 /

Enlace del recurso
Series

Human tumor antigens as therapeutic targets of cancer

Enlace del recurso
Series

Pharmacotherapy of osteoporosis part 2 of 2 /

Enlace del recurso
Series

Glucocorticoids, inflammation and bone loss

Enlace del recurso
Series

Nanotechnology platforms for cancer, and beyond

Enlace del recurso
Series

Pharmacometrics in pain management

Enlace del recurso

Pharmacometrics in psychiatry

Enlace del recurso

Osteoporosis how long to treat? /

Enlace del recurso
Series

Combination and sequential therapy for the treatment of Osteoporosis

Enlace del recurso
Series

Pharmacometric approaches to optimize use of drugs and dialysis treatments in patients with chronic kidney disease

Enlace del recurso
Series

Pharmacometrics in tuberculosis

Enlace del recurso
Series

The challenge of developing drugs for neglected parasitic diseases

Enlace del recurso
Series

Promising medical therapies for Parkinson's disease

Enlace del recurso
Series

Mechanisms of L-DOPA-induced dyskinesia in Parkinson's disease

Enlace del recurso
Series

Management of MDR and XDR TB

Enlace del recurso
Series

Acid-peptic diseases of the stomach and duodenum including Helicobacter pylori and NSAIDs

Enlace del recurso
Series

Infection in the cystic fibrosis lung

Enlace del recurso
Series

Receptors and channels in pain

Enlace del recurso
Series

Tuberculosis new treatments in evolution /

Enlace del recurso
Series

Key drug discovery challenges in cardiovascular medicine

Enlace del recurso
Series (Genetics of cardiovascular disease)
Series (Small molecule drug discovery)